Psyence: Funding, Investors & Team (Oct 2026)
Psyence (PSYG) is a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well‑being. We have a focus on these conditions in the context of palliative care. Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa. For more information: www.psyence.com
Psyence has raised $3.1M across 3 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Oct 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Psyence Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Psyence Funding Rounds
Psyence raised $680k in an undisclosed round announced in Dec 2022.
3 months later, an undisclosed round of $1.4M was announced in Mar 2023.
1.6 years later, an undisclosed round of $1.0M was announced in Oct 2024.
Psyence Founders and Leadership Team
Contact details for the Psyence team: 2 of 3 have an email address on file.
Start 14-day free trial →Psyence Funding Compared to Other Biotechnology Startups
Psyence's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Psyence in Biotechnology and Toronto
Companies Similar to Psyence
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
Psyence Funding FAQs
What does Psyence do?
Psyence (PSYG) is a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well‑being. We have a focus on these conditions in the context of palliative care. Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa. For more information: www.psyence.com
How much funding has Psyence raised?
Psyence has raised $3.1M across 3 rounds on record. The most recent is an undisclosed round of $1.0M announced in Oct 2024.
When did Psyence last raise funding?
Psyence's most recent funding round on record is an undisclosed round of $1.0M, announced in Oct 2024.
Who founded Psyence?
FundedIQ lists Dahyun Kim (Founder), Jody Aufrichtig (Founder) at Psyence.
Who is the CEO of Psyence?
Neil Maresky is listed as CEO at Psyence.
Where is Psyence headquartered?
Psyence is based in Toronto, Ontario, Canada.
How many employees does Psyence have?
Psyence is in the 1-10 employee band.
How does Psyence's funding compare to other Biotechnology startups?
Psyence's latest round of $1.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Psyence Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Psyence is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.